Search

Author/Creator Lawson, Rachael

3. Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs. Issue 3 (5th December 2019)

Authors:
Ahamadi, Malidi; Conrado, Daniela J; Macha, Sreeraj; Sinha, Vikram; Stone, Julie; Burton, Jackson; Nicholas, Timothy; Gallagher, Jill; Dexter, David; Bani, Massimo; Boroojerdi, Babak; Smit, Hans; Weidemann, Jonas; Chen, Chao; Yang, Minhua; Maciuca, Romeo; Lawson, Rachael; Burn, David; Marek, Kenn...
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 107:Issue 3(2020)
Page Start:
553
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Hospitalisation without delirium is not associated with cognitive decline in a population-based sample of older people—results from a nested, longitudinal cohort study. (3rd May 2021)

Authors:
Richardson, Sarah J; Lawson, Rachael; Davis, Daniel H J; Stephan, Blossom C M; Robinson, Louise; Matthews, Fiona E; Brayne, Carol; Barnes, Linda E; Taylor, John-Paul; Parker, Stuart G; Allan, Louise M
Journal:
Age and ageing
Issue:
Volume 50:Number 5(2021)
Page Start:
1675
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Population pharmacokinetic model for once‐daily intravenous busulfan in pediatric subjects describing time‐associated clearance. (16th June 2022)

Authors:
Lawson, Rachael; Staatz, Christine E.; Fraser, Christopher J.; Ramachandran, Shanti; Teague, Lochie; Mitchell, Richard; O'Brien, Tracey; Hennig, Stefanie
Journal:
CPT: pharmacometrics & systems pharmacology
Issue:
Volume 11:Number 8(2022)
Page Start:
1002
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗